5-Chloropyrimidine-2-carboxylic acid

Catalog No.: 
ACUPXH591
CAS No.: 
38275-61-5
Molecular Formula: 
C5H3ClN2O2
Molecular Weight: 
158.54
5-Chloropyrimidine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$62.00In stockInquiry
5g97%$214.00In stockInquiry
25g97%$895.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloropyrimidine-2-carboxylic acid
IUPAC Name5-chloropyrimidine-2-carboxylic acid
MDL No.MFCD07440094
Molecular FormulaC5H3ClN2O2
Molecular Weight158.54
SMILESOC(=O)C1=NC=C(Cl)C=N1
InChI KeyQAHZTYHFUHDFAW-UHFFFAOYSA-N
Synonym5-chloropyrimidine-2-carboxylic Acid | 38275-61-5 | 5-chloro-pyrimidine-2-carboxylic acid | MFCD07440094 | SCHEMBL286703 | DTXSID70427987 | QAHZTYHFUHDFAW-UHFFFAOYSA-N | 5-chloropyrimidine-2-carboxylicAcid | AKOS000320044 | CS-W005396 | PB13081 | AM803820 | DS-15413 | SY029327 | 5-C
CAS No.38275-61-5
PubChem CID7140348

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUPXH591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXAHR043 route compound structure diagram
    ACXAHR043894797-00-3In Stock
  2. Then
  3. ACUPXH591 route product structure diagram
    ACUPXH59138275-61-5In Stock
Inquiry

2. ACUPXH591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWOIG176 route compound structure diagram
    ACWOIG1761227571-82-5In Stock
  2. Then
  3. ACUPXH591 route product structure diagram
    ACUPXH59138275-61-5In Stock
Inquiry

3. ACUPXH591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUPXH591 route product structure diagram
    ACUPXH59138275-61-5In Stock
Inquiry

Comments (0)